Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Dec 15;229(1-2):256-62.
doi: 10.1016/j.jneuroim.2010.08.023.

IVIg inhibits classical pathway activity and anti-GM1 IgM-mediated complement deposition in MMN

Sanne Piepers  1 , Marc D Jansen, Elisabeth A Cats, Nina M van Sorge, Leonard H van den Berg, W-Ludo van der Pol
Affiliations

IVIg inhibits classical pathway activity and anti-GM1 IgM-mediated complement deposition in MMN

Sanne Piepers et al. J Neuroimmunol. .

Abstract

The effects of intravenous immunoglobulins (IVIg) on anti-GM1 IgM titer and function, classical complement pathway activity, and antibody-complement interaction were investigated in 62 patients with multifocal motor neuropathy (MMN). In vitro, IVIg decreased complement deposition by anti-GM1 IgM antibodies. First IVIg treatment (2 g/kg) decreased C1q and C4 concentrations and classical pathway activity in serum. In sera from patients receiving IVIg maintenance therapy (0.4 g/kg) C4 concentrations and classical pathway activity were generally lower at higher IgG concentrations. The beneficial effects of IVIg in MMN may be explained by reduced antibody-mediated complement deposition in nerves amplified by a systemically attenuated classical pathway.

PubMed Disclaimer

MeSH terms

LinkOut - more resources